RLMD - RELMADA THERAPEUTICS, INC.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 3.95

Open

$ 3.62

Bid

$ 3.94 x 100

Ask

$ 3.97 x 402

Day's Range

$ 3.39 - $ 4.31

52 Week Range

$ 0.24 - $ 4.34

Volume

2,301,237

Average Volume

Market Cap

131.11M

Beta (5Y Monthly)

$ 1.45

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-12-2025	03-31-2025	10-Q
4	03-27-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	03-19-2024	12-31-2023	10-K
9	11-08-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-23-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	03-25-2022	12-31-2021	10-K
17	11-12-2021	09-30-2021	10-Q
18	08-10-2021	06-30-2021	10-Q
19	05-12-2021	03-31-2021	10-Q
20	03-24-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q
22	08-12-2020	06-30-2020	10-Q
23	05-15-2020	03-31-2020	10-Q
24	11-13-2019	09-30-2019	10-Q
25	09-24-2019	06-30-2019	10-K
26	05-15-2019	03-31-2019	10-Q
27	02-13-2019	12-31-2018	10-Q
28	11-13-2018	09-30-2018	10-Q
29	09-28-2018	06-30-2018	10-K
30	05-14-2018	03-31-2018	10-Q
31	02-12-2018	12-31-2017	10-Q
32	11-14-2017	09-30-2017	10-Q
33	09-28-2017	06-30-2017	10-K
34	05-15-2017	03-31-2017	10-Q
35	02-10-2017	12-31-2016	10-Q
36	11-10-2016	09-30-2016	10-Q
37	09-09-2016	06-30-2016	10-K
38	05-09-2016	03-31-2016	10-Q
39	02-05-2016	12-31-2015	10-Q
40	11-06-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Relmada Therapeutics Q3 EPS $(0.30) Misses...
11/13/2025 21:03:08

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

a-glimpse-of-relmada-therapeuticss-earnings-potential

A Glimpse of Relmada Therapeutics's Earnin...
11/12/2025 18:02:45

Relmada Prices $100M Equity Offering Inclu...
11/04/2025 12:16:23

Relmada Receives FDA Support For Two Regis...
11/04/2025 12:08:53

12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 12:05:48

12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

Relmada Regains Compliance With Nasdaq $1 ...
09/16/2025 13:05:17

Relmada CEO Sergio Traversa Reports 91% Co...
09/10/2025 11:18:38

12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

Relmada Therapeutics CMO Raj S. Pruthi Pur...
09/02/2025 15:40:12

On August 29, 2025, Raj S. Pruthi, MD, Chief Medical Officer-Urology of Relmada Therapeutics, Inc. (the "Company"), pur...

12 Health Care Stocks Moving In Friday's I...
08/29/2025 17:05:57

12 Health Care Stocks Moving In Friday's P...
08/29/2025 12:07:49

12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Relmada Therapeutics Q2 EPS $(0.30) Misses...
08/07/2025 20:07:15

Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket

Why Medpace Shares Are Trading Higher By 4...
07/22/2025 09:39:38

Relmada Therapeutics Terminates License Ag...
07/10/2025 20:57:14

-SEC Filing